Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 436.73M | 419.17M | 401.20M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 436.73M | 419.17M | 401.20M | |
| Cost of Revenue | -- | 68.24M | 66.82M | 62.60M | |
| Gross Profit | -- | 368.50M | 352.35M | 338.61M | |
| SG&A Expenses | -- | 197.13M | 189.93M | 183.29M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 372.78M | 359.25M | 344.30M | |
| Operating Income | -- | 63.96M | 59.93M | 56.90M | |
| Income Before Tax | -- | -144.52M | -187.33M | -275.98M | |
| Income Tax Expenses | -- | 6.43M | 6.91M | 7.02M | |
| Earnings from Continuing Operations | -- | -150.95 | -194.24 | -283.01 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -150.95M | -194.24M | -283.01M | |
| EBIT | -- | 63.96M | 59.93M | 56.90M | |
| EBITDA | -- | 74.53M | 70.48M | 67.51M | |
| EPS Basic | -- | -0.76 | -0.96 | -1.39 | |
| Normalized Basic EPS | -- | 0.11 | -0.02 | -0.02 | |
| EPS Diluted | -- | -0.76 | -0.96 | -1.40 | |
| Normalized Diluted EPS | -- | 0.11 | -0.02 | -0.02 | |
| Average Basic Shares Outstanding | -- | 919.56M | 878.15M | 837.73M | |
| Average Diluted Shares Outstanding | -- | 954.34M | 904.31M | 851.83M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |